Back to News
Market Impact: 0.2
Clene Announces Closing of $4 Million Registered Direct Offering Extending Capital Runway Beyond FDA Decision on CNM-Au8® NDA
Source: GlobeNewswire
Healthcare & BiotechCapital Returns (Dividends / Buybacks)
Clene Inc. closed a registered direct common-stock offering to existing shareholders, including insiders, raising $4 million in gross proceeds. The financing provides incremental capital for the clinical-stage ALS-focused biotechnology company but may dilute existing shareholders.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
CLNN0.15
More News
- Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction
- Globus Medical stock holds at Neutral as BTIG cites revenue miss
- Vistra Reports Third Quarter 2026 Results
- Oppenheimer reiterates Outperform on HA Sustainable stock, $52 target
- South Korean corporate reforms hit rough patch as Samsung digs in
- Toyota hikes annual outlook and unveils $89 billion shareholder return plan